These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28854264)

  • 1. Oral glucose tolerance test predicts increased carotid plaque burden in patients with acute coronary syndrome.
    Bjarnason TA; Hafthorsson SO; Kristinsdottir LB; Oskarsdottir ES; Aspelund T; Sigurdsson S; Gudnason V; Andersen K
    PLoS One; 2017; 12(8):e0183839. PubMed ID: 28854264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editor's Choice- Diagnosis of type 2 diabetes and prediabetes among patients with acute coronary syndromes.
    Bjarnason TA; Kristinsdottir LB; Oskarsdottir ES; Hafthorsson SO; Olafsson I; Lund SH; Andersen K
    Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):744-749. PubMed ID: 27625341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients.
    Scicali R; Giral P; Gallo A; Di Pino A; Rabuazzo AM; Purrello F; Cluzel P; Redheuil A; Bruckert E; Rosenbaum D
    Atherosclerosis; 2016 Dec; 255():102-108. PubMed ID: 27870948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of oral glucose tolerance test and HbA1c in detection of disorders of glucose metabolism in patients with acute stroke.
    Matz K; Tuomilehto J; Teuschl Y; Dachenhausen A; Brainin M
    Cardiovasc Diabetol; 2020 Dec; 19(1):204. PubMed ID: 33278898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carotid atherosclerosis severity in relation to glycemic status: a cross-sectional population study.
    Mostaza JM; Lahoz C; Salinero-Fort MA; de Burgos-Lunar C; Laguna F; Estirado E; García-Iglesias F; González-Alegre T; Cornejo-Del-Río V; Sabín C; López S;
    Atherosclerosis; 2015 Oct; 242(2):377-82. PubMed ID: 26275375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of mismatches in HbA
    Gonzalez A; Deng Y; Lane AN; Benkeser D; Cui X; Staimez LR; Ford CN; Khan FN; Markley Webster SC; Leong A; Wilson PWF; Phillips LS; Rhee MK
    Diabet Med; 2020 Apr; 37(4):689-696. PubMed ID: 31721287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of atherosclerosis in individuals with prediabetes and diabetes compared to normoglycaemic individuals-a Swedish population-based study.
    Östgren CJ; Otten J; Festin K; Angerås O; Bergström G; Cederlund K; Engström G; Eriksson MJ; Eriksson M; Fall T; Gummesson A; Hagström E; Hellman U; James SK; Jernberg T; Kihlberg J; Kylhammar D; Markstad H; Nilsson P; Persson A; Persson M; Pirazzi C; Renklint R; Rosengren A; Söderberg S; Sundström J
    Cardiovasc Diabetol; 2023 Sep; 22(1):261. PubMed ID: 37759237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term prognosis in patients with acute myocardial infarction and newly detected glucose abnormalities: predictive value of oral glucose tolerance test and HbA1c.
    Karayiannides S; Djupsjö C; Kuhl J; Hofman-Bang C; Norhammar A; Holzmann MJ; Lundman P
    Cardiovasc Diabetol; 2021 Jun; 20(1):122. PubMed ID: 34126971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic effect of known and newly detected type 2 diabetes in patients with acute coronary syndrome.
    Bjarnason TA; Hafthorsson SO; Kristinsdottir LB; Oskarsdottir ES; Johnsen A; Andersen K
    Eur Heart J Acute Cardiovasc Care; 2020 Sep; 9(6):608-615. PubMed ID: 31107107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of atheromatosis in the prediabetes stage: a cross-sectional investigation of the ILERVAS project.
    Sánchez E; Betriu À; López-Cano C; Hernández M; Fernández E; Purroy F; Bermúdez-López M; Farràs-Sallés C; Barril S; Pamplona R; Rius F; Hernández C; Simó R; Lecube A;
    Cardiovasc Diabetol; 2019 Nov; 18(1):154. PubMed ID: 31729979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can prediabetes diagnosed using HemoglobinA1c or oral glucose tolerance test predict presence and severity of coronary artery disease in symptomatic patients?
    Overgaard KS; Andersen TR; Mohamed RA; Heinsen LJ; Binderup HG; Möller S; Auscher S; Lambrechtsen J; Egstrup K
    Diab Vasc Dis Res; 2023; 20(3):14791641231179870. PubMed ID: 37344962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of the Hemoglobin Glycation Index on the Diagnosis of Prediabetes and Diabetes.
    Hsia DS; Rasouli N; Pittas AG; Lary CW; Peters A; Lewis MR; Kashyap SR; Johnson KC; LeBlanc ES; Phillips LS; Hempe JM; Desouza CV;
    J Clin Endocrinol Metab; 2020 Mar; 105(3):e130-8. PubMed ID: 31965161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum 25-Hydroxyvitamin D3 Levels Are Associated with Carotid Intima-Media Thickness and Carotid Atherosclerotic Plaque in Type 2 Diabetic Patients.
    Wang Y; Zhang H
    J Diabetes Res; 2017; 2017():3510275. PubMed ID: 28459072
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of prediabetes in patients with acute coronary syndrome: impact on in-hospital outcomes.
    AbuShady MM; Mohamady Y; Enany B; Nammas W
    Intern Med J; 2015 Feb; 45(2):183-8. PubMed ID: 25443454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasting glucose, HbA1c, or oral glucose tolerance testing for the detection of glucose abnormalities in patients with acute coronary syndromes.
    Hage C; Lundman P; Rydén L; Mellbin L
    Eur J Prev Cardiol; 2013 Aug; 20(4):549-54. PubMed ID: 22456695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta.
    Mizoguchi M; Tahara N; Tahara A; Nitta Y; Kodama N; Oba T; Mawatari K; Yasukawa H; Kaida H; Ishibashi M; Hayabuchi N; Harada H; Ikeda H; Yamagishi S; Imaizumi T
    JACC Cardiovasc Imaging; 2011 Oct; 4(10):1110-8. PubMed ID: 21999871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 1h post glucose value best predicts future dysglycemia among normal glucose tolerance subjects.
    Sai Prasanna N; Amutha A; Pramodkumar TA; Anjana RM; Venkatesan U; Priya M; Pradeepa R; Mohan V
    J Diabetes Complications; 2017 Nov; 31(11):1592-1596. PubMed ID: 28916170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dysregulation of glucose metabolism control is associated with carotid atherosclerosis in patients with coronary heart disease (CORDIOPREV-DIAB study).
    Yubero-Serrano EM; Delgado-Lista J; Alcala-Diaz JF; Garcia-Rios A; Perez-Caballero AI; Blanco-Rojo R; Gomez-Delgado F; Marin C; Tinahones FJ; Caballero J; Ordovas JM; van Ommen B; Perez-Jimenez F; Perez-Martinez P; Lopez-Miranda J
    Atherosclerosis; 2016 Oct; 253():178-185. PubMed ID: 27451413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of prediabetes and newly diagnosed diabetes in patients with a transient ischemic attack or stroke.
    Fonville S; Zandbergen AA; Vermeer SE; Dippel DW; Koudstaal PJ; den Hertog HM
    Cerebrovasc Dis; 2013; 36(4):283-9. PubMed ID: 24135458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 1,5-anhydroglucitol levels on culprit plaque rupture in diabetic patients with acute coronary syndrome.
    Su G; Gao MX; Shi GL; Dai XX; Yao WF; Zhang T; Zhuang SW
    Cardiovasc Diabetol; 2020 May; 19(1):71. PubMed ID: 32473648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.